treatment | CMAC

treatment

Clinical Features and Course of Pneumocystis Pneumonia in Non-HIV Patients

Clinical Microbiology and Antimicrobial Chemotherapy.2004; 6(3):243-251
As a result of the increase in the number of diseases and conditions that are leading to secondary immunodeficiency, the problem of severe opportunistic infections becoming more and more actual.In the present article authors have described and …

A Problem of Sarcoidosis Treatment: Cause for Discussion and Controlled Trials

Clinical Microbiology and Antimicrobial Chemotherapy.2004; 6(3):232-242
This literature review presents approaches to the treatment of sarcoidosis, which are based on currently offered hypothesis of its pathogensis.These include: influence on granulomatous inflammation (corticosteroids, cytotoxic agents, anti-malaria …

Genital Herpes: Recent Problems and Their Solutions

Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(1):4-18
Genital herpes (GH) is widely distributed sexually transmitted disease that is caused by herpes simplex virus type 1 nd 2. This article presents the questions of epidemiology and pathogenesis of this infection. Clinical features and major criteria …

EAU Guidelines for the Management of Urinary and Male Genital Tract Infections

Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(4):347-363
A short version of the UTI Guidelines elaborated by the Urinary Tract Infection Working Group of the Health Care Office of the European Association of Urology is presented. The topics include classification, diagnosis, treatment and follow+up of …

New developments in the treatment of infective endocarditis infective cardiovasculitis

Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(3):32-47
Translated and reprinted with permission from «International Journal of Antimicrobial Agents» 1999; 13:79-92.

The natural history of infective endocarditis has undergone remarkable changes over the past 100 years as regards both the demographic …